Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Investing.com -- Allurion Technologies Inc (NYSE: ALUR) stock rose 2.9% following the announcement of a strategic distribution partnership with Minogue Medical Inc., a Canadian medical device company ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

EXPERTS have revealed the golden dose of Mounjaro that helps shift the most weight – and it’s not the highest one. Weight ...

TV outcomes company EDO unveiled the most effective TV ads from the first half of 2025, spotlighting the creatives that drove ...

So far, benefits associated with consistent GLP-1 use in curbing medical spending lack sufficient data-backed evidence. It’s ...

New data from The Ohio State University Wexner Medical Center Comprehensive Transplant Center shows obese patients with end stage kidney disease and diabetes can safely use weight loss injections to ...

Novo Nordisk's beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year. Eli Lilly's ...

It’s also key to ensure that patients still get a wide variety of nutrients, including tons of protein, to prevent any nutritional deficiencies. Medical management of any G.I. side effects, which can ...

G lucagon-like peptide-1 receptor agonists (GLP-1RA) drugs, such as Ozempic and Wegovy, are often referred to as "miracle ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the future.

Hims and Hers announced this morning that it will begin offering compounded semaglutide (generic Ozempic or Wegovy) for $199 ...